Cosmetic cross-reference

Lactose

CAS 63-42-3

Lactose (CAS 63-42-3) is a pharmaceutical compound with 3 bioactivity targets and 182 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
3
SOURCE DrugCentral
Adverse signals
182
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE DrugCentral 055904D152D6

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Lactose
CAS Number
63-42-3
UNII
3SY5LH9PMK
InChIKey
GUBGYTABKSRVRQ-XLOQQCSPSA-N
ChEMBL ID
CHEMBL2106323
DrugCentral Struct ID
1535
Source Match
DrugCentral (CAS), FDA GSRS (UNII)
Synonyms and normalized names
ANHYDROUS LACTOSELACTOSE, ANHYDROUS
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE EMBL-EBI ChEMBL 3 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
Galectin-8
Unclassified
 Kd 4.21 - Homo sapiens
Galectin-9
Unclassified
 Kd 4.64 - Homo sapiens
Galectin-3
Unclassified
 Kd 4.03 - Homo sapiens
SOURCE DrugCentral 14 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Allergic reaction to excipient 23 141.591 10078853
Oesophagitis 30 76.303 10030216
Drug hypersensitivity 72 65.999 10013700
Allergy to metals 10 47.545 10066414
Dehydration 52 47.454 10012174
Iodine allergy 10 47.332 10052098
Rubber sensitivity 10 37.883 10039251
Eye oedema 10 37.853 10052139
Radiation oesophagitis 8 37.475 10048899
Dysphagia 32 34.102 10013950
Reaction to excipient 8 29.984 10079925
Hypophagia 17 24.195 10063743
Pneumonitis 19 24.171 10035742
Angioedema 20 22.951 10002424

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 9 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
LACTOSE 6211 SU MTHSPL
Lactose 6211 SU MTHSPL
lactose 6211 SU MTHSPL
ANHYDROUS LACTOSE 1307662 SU MTHSPL
Anhydrous Lactose 1307662 SU MTHSPL
Anhydrous lactose 1307662 SU MTHSPL
LACTOSE, ANHYDROUS 1307662 SU MTHSPL
anhydrous lactose 1307662 SU MTHSPL
lactose 6211 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Lactose used for in pharmaceutical contexts?

Lactose (CAS 63-42-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Lactose?

Lactose has 182 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Allergic reaction to excipient, Oesophagitis, Drug hypersensitivity, Allergy to metals, Dehydration. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Lactose also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Lactose with EU status "permitted".

What clinical phase is Lactose in?

No phase 1-4 clinical development badge is rendered for Lactose because the matched compound identifier rows do not contain a max-phase value.

What bioactivity targets are documented for Lactose?

Lactose has 3 bioactivity rows in this page query. Rendered target entries include Galectin-8, Galectin-9, Galectin-3.